A preliminary study of IgG4 expression and its prognostic significance in oral squamous cell carcinoma

BMC Cancer. 2024 Mar 4;24(1):294. doi: 10.1186/s12885-024-12048-5.

Abstract

Background: IgG4, which plays a pivotal role in the progression of phenotypically diverse tumors, serves as a prognostic marker because of its influence on cancer immunity. Nevertheless, the functions of IgG4 in tongue squamous cell carcinoma (TSCC) remained to be identified.

Methods: To evaluate the significance of IgG4 expression in TSCC, we performed immunohistochemical analysis of patients with TSCC (n = 50) to evaluate the correlation of IgG4 expression with patients' clinicopathological features and prognoses.

Results: Higher IgG4 expression detected in TSCC tissues was associated with the less advanced mode of invasion (Yamamoto-Kohama [YK] 1-3) (P = 0.031) and with well-differentiated TSCC (P = 0.077). Kaplan-Meier analyses revealed that the higher IgG4 expression group exhibited better prognosis indicated by overall survival (OS) (P = 0.04) and recurrence-free survival (RFS) (P = 0.016). Univariate analysis of OS indicated that IgG4 expression was associated with longer OS (P = 0.061), and multivariate analysis of RFS revealed that IgG4 expression served as an independent prognostic factor for longer RFS (P = 0.005).

Conclusion: These results indicate that relatively higher IgG4 levels serve as a favorable prognostic factor for TSCC.

Keywords: Favorable prognostic factor; IgG4; Tongue squamous cell carcinoma.

MeSH terms

  • Carcinoma, Squamous Cell*
  • Head and Neck Neoplasms*
  • Humans
  • Immunoglobulin G
  • Mouth Neoplasms*
  • Prognosis
  • Squamous Cell Carcinoma of Head and Neck
  • Tongue Neoplasms*

Substances

  • Immunoglobulin G